Literature DB >> 26067434

Reliability and Validity of Proposed DSM-5 ADHD Symptoms in a Clinical Sample of Adults.

Breno Matte1, Luis Augusto Rohde1, J Blake Turner1, Prudence W Fisher1, Sa Shen1, Claiton H D Bau1, Joel T Nigg1, Eugenio H Grevet1.   

Abstract

The DSM-5 ADHD and Disruptive Behaviors Work Group proposed two major changes for diagnosis of attention deficit hyperactivity disorder (ADHD) in adults: (1) inclusion of four new impulsivity symptoms and (2) reduction in the number of symptoms required for assigning an ADHD diagnosis. In this case-control study, the performance of these modifications was assessed in a clinical sample of 133 adult subjects (68 ADHD cases and 65 non-ADHD control subjects). The proposed new impulsivity symptoms for adults do not improve ADHD diagnosis enough to overcome potential negative effects of changing the criteria. However, fewer symptoms than the six-of-nine threshold required by DSM-IV provided the best cutoff point for identifying adults who are impaired.

Entities:  

Mesh:

Year:  2015        PMID: 26067434     DOI: 10.1176/appi.neuropsych.13060137

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  8 in total

1.  Validity of proposed DSM-5 ADHD impulsivity symptoms in children.

Authors:  Gül Ünsel Bolat; Eyüp Sabri Ercan; Giovanni Abrahão Salum; Öznur Bilaç; Rafael Massuti; Taciser Uysal Özaslan; Hilmi Bolat; Luis Augusto Rohde
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-03-15       Impact factor: 4.785

2.  Psychometrically Informed Approach to Integration of Multiple Informant Ratings in Adult ADHD in a Community-Recruited Sample.

Authors:  Michelle M Martel; Joel T Nigg; Ulrich Schimmack
Journal:  Assessment       Date:  2016-07-27

Review 3.  Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Wim Verbeeck; Geertruida E Bekkering; Wim Van den Noortgate; Cornelis Kramers
Journal:  Cochrane Database Syst Rev       Date:  2017-10-02

4.  Dissecting the cross-trait effects of the FOXP2 GWAS hit on clinical and brain phenotypes in adults with ADHD.

Authors:  Gabriela Pessin Meyer; Bruna Santos da Silva; Cibele Edom Bandeira; Maria Eduarda Araujo Tavares; Renata Basso Cupertino; Eduarda Pereira Oliveira; Diana Müller; Djenifer B Kappel; Stefania Pigatto Teche; Eduardo Schneider Vitola; Luis Augusto Rohde; Diego Luiz Rovaris; Eugenio Horacio Grevet; Claiton Henrique Dotto Bau
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-12       Impact factor: 5.270

Review 5.  DSM Nosology Changes in Neuropsychological Diagnoses through the Years: A Look at ADHD and Mild Neurocognitive Disorder.

Authors:  Anne R Carlew; Andrea L Zartman
Journal:  Behav Sci (Basel)       Date:  2016-12-29

6.  Behavioral and Neurophysiological Markers of ADHD in Children, Adolescents, and Adults: A Large-Scale Clinical Study.

Authors:  Marionna Münger; Gian Candrian; Johannes Kasper; Hossam Abdel-Rehim; Dominique Eich; Andreas Müller; Lutz Jäncke
Journal:  Clin EEG Neurosci       Date:  2021-03-25       Impact factor: 1.843

7.  Longitudinal Analysis of Self-Reported Symptoms, Behavioral Measures, and Event-Related Potential Components of a Cued Go/NoGo Task in Adults With Attention-Deficit/Hyperactivity Disorder and Controls.

Authors:  Marionna Münger; Silvano Sele; Gian Candrian; Johannes Kasper; Hossam Abdel-Rehim; Dominique Eich-Höchli; Andreas Müller; Lutz Jäncke
Journal:  Front Hum Neurosci       Date:  2022-02-18       Impact factor: 3.169

8.  ADHD and Academic Success in University Students: The Important Role of Impaired Attention.

Authors:  Colin Henning; Laura J Summerfeldt; James D A Parker
Journal:  J Atten Disord       Date:  2021-08-12       Impact factor: 3.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.